J. Alex Hammond
Papers
4
Total Citations
639
H-Index
3
About
Dr. J. Alex Hammond is a leading clinical researcher in head and neck oncology, best known for spearheading the landmark ORATOR clinical trials. His primary research focuses on the comparative effectiveness of radiotherapy versus transoral robotic surgery (TORS) for treating oropharyngeal squamous cell carcinoma (OPSCC), a cancer increasingly linked to HPV infection. Dr. Hammond’s most significant contribution is the ORATOR phase II randomized trial, which provided the first high-level evidence directly comparing these two curative-intent modalities. The initial results, published in 2019 and cited over 450 times, established a critical framework for treatment decision-making. His subsequent work, including the final five-year outcomes and a detailed sub-study on swallowing physiology, has profoundly impacted clinical practice by rigorously evaluating both survival and functional outcomes like swallowing preservation. With over 600 combined citations for his ORATOR publications, Dr. Hammond’s research is essential reading for any clinician or researcher navigating the complex trade-offs between surgical and radiation-based approaches in the management of oropharynx cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4